Lymphomas

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2013-08-28
Clinical Trial Update: Safety and Efficacy of GMX1777 in the Treatment of Refractory Solid Tumors or Lymphomas [Phase 1]
The Phase 1 GMX1777 trial for refractory solid tumors or lymphomas has been withdrawn.